Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

CytomX Therapeutics (CTMX) Interest Coverage Ratio (2016 - 2017)

CytomX Therapeutics' Interest Coverage Ratio history spans 4 years, with the latest figure at 41.82 for Q1 2017.

  • For Q1 2017, Interest Coverage Ratio rose 8.78% year-over-year to 41.82; the TTM value through Dec 2017 reached 224.56, down 536.52%, while the annual FY2016 figure was 35.28, 84.03% down from the prior year.
  • Interest Coverage Ratio reached 41.82 in Q1 2017 per CTMX's latest filing, down from 36.58 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 13.58 in Q2 2015 to a low of 45.84 in Q1 2016.
  • Average Interest Coverage Ratio over 4 years is 30.84, with a median of 30.66 recorded in 2016.
  • Peak YoY movement for Interest Coverage Ratio: skyrocketed 46.99% in 2015, then plummeted 125.74% in 2016.
  • A 4-year view of Interest Coverage Ratio shows it stood at 42.74 in 2014, then grew by 28.3% to 30.65 in 2015, then dropped by 19.35% to 36.58 in 2016, then decreased by 14.31% to 41.82 in 2017.
  • Per Business Quant, the three most recent readings for CTMX's Interest Coverage Ratio are 41.82 (Q1 2017), 36.58 (Q4 2016), and 30.95 (Q3 2016).